TransMedics Group, Inc. Foreign Currency Transaction Gain (Loss), Unrealized
TransMedics Group, Inc. (TMDX) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$652.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-08-04
- TransMedics Group, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2026-06-30 was -$166.00K, a 118.44% decline year-over-year.
- TransMedics Group, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2026-03-31 was -$486.00K, a 184.82% decline year-over-year.
- TransMedics Group, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-12-31 was $141.00K.
- TransMedics Group, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-09-30 was $8.00K, a 98.33% decline year-over-year.
- TransMedics Group, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2025 was $1.62M.
- TransMedics Group, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2024 was -$665.00K, a 294.44% decline from fiscal 2023.
- TransMedics Group, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2023 was $342.00K.
- TransMedics Group, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2022 was -$1.13M.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$652.00K 10-Q · filed 2026-08-04 | -$511.00K derived: sum of 3 quarters · filed 2026-08-04 | -$503.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$486.00K 10-Q · filed 2026-05-05 | -$345.00K derived: sum of 2 quarters · filed 2026-05-05 | -$337.00K derived: sum of 3 quarters · filed 2026-05-05 | $563.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $149.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.05M derived: sum of 3 quarters · filed 2026-08-04 | $1.62M 10-K · filed 2026-02-24 |
| 2025-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $908.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.48M 10-Q · filed 2025-10-29 | $536.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.47M 10-Q · filed 2026-08-04 | $528.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.01M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $573.00K 10-Q · filed 2026-05-05 | -$372.00K derived: sum of 2 quarters · filed 2026-05-05 | $108.00K derived: sum of 3 quarters · filed 2026-05-05 | $107.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$945.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$465.00K derived: sum of 2 quarters · filed 2026-02-24 | -$466.00K derived: sum of 3 quarters · filed 2026-02-24 | -$665.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $480.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $479.00K derived: sum of 2 quarters · filed 2025-10-29 | $280.00K 10-Q · filed 2025-10-29 | $740.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$200.00K 10-Q · filed 2025-07-30 | $260.00K derived: sum of 3 quarters · filed 2026-02-24 | -$8.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$199.00K 10-Q · filed 2025-05-08 | $261.00K derived: sum of 2 quarters · filed 2026-02-24 | -$7.00K derived: sum of 3 quarters · filed 2026-02-24 | $6.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $460.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $192.00K derived: sum of 2 quarters · filed 2026-02-24 | $205.00K derived: sum of 3 quarters · filed 2026-02-24 | $342.00K 10-K · filed 2026-02-24 |
| 2023-09-30 | -$268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$255.00K derived: sum of 2 quarters · filed 2024-10-29 | -$118.00K 10-Q · filed 2024-10-29 | $486.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $150.00K 10-Q · filed 2024-08-01 | $754.00K derived: sum of 3 quarters · filed 2025-02-27 | $55.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $137.00K 10-Q · filed 2024-05-02 | $741.00K derived: sum of 2 quarters · filed 2025-02-27 | $42.00K derived: sum of 3 quarters · filed 2025-02-27 | -$778.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $604.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$95.00K derived: sum of 2 quarters · filed 2025-02-27 | -$915.00K derived: sum of 3 quarters · filed 2025-02-27 | -$1.13M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$699.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.52M derived: sum of 2 quarters · filed 2023-11-08 | -$1.73M 10-Q · filed 2023-11-08 | -$2.07M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$820.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$1.03M 10-Q · filed 2023-08-04 | -$1.38M derived: sum of 3 quarters · filed 2024-02-27 | -$1.65M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$214.00K 10-Q · filed 2023-05-04 | -$555.00K derived: sum of 2 quarters · filed 2024-02-27 | -$828.00K derived: sum of 3 quarters · filed 2024-02-27 | -$658.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$341.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$614.00K derived: sum of 2 quarters · filed 2024-02-27 | -$444.00K derived: sum of 3 quarters · filed 2024-02-27 | -$928.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | -$273.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$103.00K derived: sum of 2 quarters · filed 2022-11-04 | -$587.00K 10-Q · filed 2022-11-04 | -$45.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$314.00K 10-Q · filed 2022-08-03 | $228.00K derived: sum of 3 quarters · filed 2023-02-27 | $620.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$484.00K 10-Q · filed 2022-05-05 | $58.00K derived: sum of 2 quarters · filed 2023-02-27 | $450.00K derived: sum of 3 quarters · filed 2023-02-27 | $659.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $542.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $934.00K derived: sum of 2 quarters · filed 2023-02-27 | $1.14M derived: sum of 3 quarters · filed 2023-02-27 | $1.06M 10-K · filed 2023-02-27 |
| 2020-09-30 | $392.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $601.00K derived: sum of 2 quarters · filed 2021-11-09 | $523.00K 10-Q · filed 2021-11-09 | $715.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $131.00K 10-Q · filed 2021-08-06 | $323.00K derived: sum of 3 quarters · filed 2021-05-07 | |
| 2020-03-31 | -$78.00K 10-Q · filed 2021-05-07 | $114.00K derived: sum of 2 quarters · filed 2021-05-07 | ||
| 2019-12-28 | $192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$200.00K 10-K · filed 2021-03-11 | ||
| 2019-09-28 | -$392.00K 10-Q · filed 2019-11-08 | |||
| 2019-03-30 | -$160.00K 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | -$150.00K 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $10.00K 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | -$153.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$10.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $143.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |